ECSP982521A - CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) - Google Patents
CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I)Info
- Publication number
- ECSP982521A ECSP982521A ECSP982521A ECSP982521A EC SP982521 A ECSP982521 A EC SP982521A EC SP982521 A ECSP982521 A EC SP982521A EC SP982521 A ECSP982521 A EC SP982521A
- Authority
- EC
- Ecuador
- Prior art keywords
- crystal modification
- medicinal substance
- active medicinal
- modification
- active
- Prior art date
Links
- 230000004048 modification Effects 0.000 title abstract 3
- 238000012986 modification Methods 0.000 title abstract 3
- 239000013078 crystal Substances 0.000 title abstract 2
- 239000012907 medicinal substance Substances 0.000 title 1
- OSKSVLBJJXQUPI-UHFFFAOYSA-N 2h-triazole-4-carboxamide Chemical compound NC(=O)C1=CNN=N1 OSKSVLBJJXQUPI-UHFFFAOYSA-N 0.000 abstract 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a la nueva modificación A, o bien A¿del compuesto 1-2(2,6-difluorbencial)-1H-1,2,3, triazol-4-carboxamida de la fórmula (gráfico), su empleo, así como preparados farmacéuticos que contienen esta modificación a cristal.The invention relates to the new modification A, or A¿ of compound 1-2 (2,6-difluorobenz) -1H-1,2,3, triazol-4-carboxamide of the formula (graph), its use, as well as pharmaceutical preparations containing this crystal modification.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982521 ECSP982521A (en) | 1998-06-05 | 1998-06-05 | CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982521 ECSP982521A (en) | 1998-06-05 | 1998-06-05 | CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982521A true ECSP982521A (en) | 1999-02-11 |
Family
ID=42043442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982521 ECSP982521A (en) | 1998-06-05 | 1998-06-05 | CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982521A (en) |
-
1998
- 1998-06-05 EC ECSP982521 patent/ECSP982521A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0207726A (en) | Pharmaceutical Salts | |
| ES2179910T3 (en) | CRYSTAL MODIFICATION OF THE CDCH, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. | |
| ES2084702T3 (en) | SUBSTITUTED IMIDAZOLES USEFUL AS ANGIOTENSIN II INHIBITORS. | |
| EE03969B1 (en) | (Methylsulfonyl) phenyl-2- (5H) -furanones, their Use and Pharmaceutical Compositions | |
| ES2159591T3 (en) | COMPOSITION OF CONTROLLED RELEASE. | |
| AR003938A1 (en) | TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES. | |
| DE60030741D1 (en) | CHINAZOLINE COMPOUNDS AS A REMEDY | |
| PT750618E (en) | OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| BR9909565A (en) | Bicyclic derivatives of hydroxamic acid | |
| BR9916585A (en) | Ccr5 modulators | |
| EA200000759A1 (en) | DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA | |
| BR9917007A (en) | Ccr5 modulators | |
| DK0994710T4 (en) | Pharmaceutical compositions for oral administration comprising a benzylhydrylpiperazine and a cyclodextrin | |
| IS2750B (en) | conductor mount | |
| ES2171723T3 (en) | 3,4-DIARIL-2-HYDROXI-2,5-DIHYDROFURANS AS COX-2 INHIBITORS PROPHARMS. | |
| BR0111678A (en) | Medicinal compositions containing propenone derivatives | |
| CY1110402T1 (en) | PHARMACEUTICAL AND COSMETIC PREPARATIONS FOR NON-CARE | |
| SV1998000119A (en) | DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE. REF. READ 32671-SV | |
| CO4940452A1 (en) | CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE | |
| SE9801494D0 (en) | Novel use | |
| DK0930077T3 (en) | Cyclodextrin preparations containing an avermectin or milbemycin derivative | |
| DE60128100D1 (en) | ANALGICAL DRUG | |
| TW200507838A (en) | Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator | |
| EE200100188A (en) | Optically active pyridyl-4H-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
| ECSP982521A (en) | CRYSTAL MODIFICATION OF AN ACTIVE MEDICINAL SUBSTANCE (I) |